Genetic imaging consortium for addiction medicine: From neuroimaging to genes

Publikation: Beitrag in FachzeitschriftÜbersichtsartikel (Review)BeigetragenBegutachtung

Beitragende

  • Scott Mackey - , University of Vermont (Autor:in)
  • Kees-Jan Kan - , University of Vermont (Autor:in)
  • Bader Chaarani - , University of Vermont (Autor:in)
  • Nelly Alia-Klein - , Icahn School of Medicine at Mount Sinai (Autor:in)
  • Albert Batalla - , Universitat de Barcelona (Autor:in)
  • Samantha Brooks - , University of Cape Town (Autor:in)
  • Janna Cousijn - , University of Cape Town (Autor:in)
  • Alain Dagher - , McGill University (Autor:in)
  • Michiel de Ruiter - , Netherlands Cancer Institute (Autor:in)
  • Sylvane Desrivieres - , King's College London (KCL) (Autor:in)
  • Sarah W Feldstein Ewing - , Oregon Health and Science University (Autor:in)
  • Rita Z Goldstein - , Icahn School of Medicine at Mount Sinai (Autor:in)
  • Anna E Goudriaan - , University of Cape Town (Autor:in)
  • Mary M Heitzeg - , University of Michigan, Ann Arbor (Autor:in)
  • Kent Hutchison - , University of Colorado Boulder (Autor:in)
  • Chiang-Shan R Li - , Yale University (Autor:in)
  • Edythe D London - , University of California at Los Angeles (Autor:in)
  • Valentina Lorenzetti - , Monash University (Autor:in)
  • Maartje Luijten - , Radboud University Nijmegen (Autor:in)
  • Rocio Martin-Santos - , Universitat de Barcelona (Autor:in)
  • Angelica M Morales - , University of California at Los Angeles (Autor:in)
  • Martin P Paulus - , University of California at San Diego (Autor:in)
  • Tomas Paus - , University of Toronto (Autor:in)
  • Godfrey Pearlson - , Yale University (Autor:in)
  • Renée Schluter - , University of Amsterdam (Autor:in)
  • Reza Momenan - , National Institute on Alcohol Abuse and Alcoholism (Autor:in)
  • Lianne Schmaal - , Amsterdam University Medical Centers (UMC) (Autor:in)
  • Gunter Schumann - , King's College London (KCL) (Autor:in)
  • Rajita Sinha - , Yale University (Autor:in)
  • Zsuzsika Sjoerds - , Max-Planck-Institut für Kognitions- und Neurowissenschaften (Autor:in)
  • Dan J Stein - , University of Cape Town (Autor:in)
  • Elliot A Stein - , National Institute of Drug Abuse (Autor:in)
  • Nadia Solowij - , University of Wollongong (Autor:in)
  • Susan Tapert - , Laureate Institute for Brain Research (Autor:in)
  • Anne Uhlmann - , Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, University of Cape Town (Autor:in)
  • Dick Veltman - , Amsterdam University Medical Centers (UMC) (Autor:in)
  • Ruth van Holst - , University of Amsterdam (Autor:in)
  • Henrik Walter - , Charité – Universitätsmedizin Berlin (Autor:in)
  • Margaret J Wright - , QIMR Berghofer Medical Research Institute (Autor:in)
  • Murat Yucel - , Monash University (Autor:in)
  • Deborah Yurgelun-Todd - , University of Utah (Autor:in)
  • Derrek P Hibar - , University of Southern California (Autor:in)
  • Neda Jahanshad - , University of Southern California (Autor:in)
  • Paul M Thompson - , University of Southern California (Autor:in)
  • David C Glahn - , Yale University (Autor:in)
  • Hugh Garavan - , University of Vermont (Autor:in)
  • Patricia Conrod - , CHU Ste Justine Hospital (Autor:in)

Abstract

Since the sample size of a typical neuroimaging study lacks sufficient statistical power to explore unknown genomic associations with brain phenotypes, several international genetic imaging consortia have been organized in recent years to pool data across sites. The challenges and achievements of these consortia are considered here with the goal of leveraging these resources to study addiction. The authors of this review have joined together to form an Addiction working group within the framework of the ENIGMA project, a meta-analytic approach to multisite genetic imaging data. Collectively, the Addiction working group possesses neuroimaging and genomic data obtained from over 10,000 subjects. The deadline for contributing data to the first round of analyses occurred at the beginning of May 2015. The studies performed on this data should significantly impact our understanding of the genetic and neurobiological basis of addiction.

Details

OriginalspracheEnglisch
Seiten (von - bis)203-23
Seitenumfang21
FachzeitschriftProgress in brain research
Jahrgang224
PublikationsstatusVeröffentlicht - 2016
Peer-Review-StatusJa

Externe IDs

PubMedCentral PMC4820288
Scopus 84964978242
ORCID /0000-0002-1753-7811/work/142248181

Schlagworte

Schlagwörter

  • Brain/diagnostic imaging, Genetic Testing, Humans, Meta-Analysis as Topic, Neuroimaging, Phenotype, Substance-Related Disorders/drug therapy